Roche CEO Schinecker wants a bite of the weight loss drugs market
Source: SeekingAlpha
2026-03-03 11:35:08 ET
More on Roche
- Roche Holding AG (RHHBY) Shareholder/Analyst Presentation
- Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- ClearBridge International Growth ACWI Ex-US Strategy adds and exits multiple positions
- Roche granted FDA review for novel breast cancer therapy
Read the full article on Seeking Alpha
For further details see:
Roche CEO Schinecker wants a bite of the weight loss drugs market
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-2.37% G/L:
$50.70 Last:
1,323,065 Volume:
$51.31 Open:
RHHBY Latest News
March 16, 2026 02:00:00 am
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
March 09, 2026 02:10:00 am
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
